PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
61.55
Similar ESG score to RVPHW's 63.02. Bruce Berkowitz would investigate if industry ESG norms adequately address regulatory risks.
53.79
Environmental score below 80% of RVPHW's 70.36. Jim Chanos would check for potential stranded asset risks and carbon liabilities.
66.06
Social score exceeding 1.2x RVPHW's 54.02. Mohnish Pabrai would examine if this social advantage creates sustainable talent and customer acquisition advantages.
64.79
Similar governance score to RVPHW's 64.69. Bruce Berkowitz would investigate if industry governance norms adequately protect shareholder value.